<!DOCTYPE html>

<!--
  Created : 1/26/2012 1:57 PM
  Author : Tom Coleman
  Copyright : 2011-2011
  By : University of Missippi Medical Center
-->

<html>
<head>
<title> Model </title>
<link rel='stylesheet' type='text/css' href='../../Style.CSS'>
</head>

<body>

<img src='../../SmallTitle.PNG'>
<img src='../XMLLightBlue.png'>
<a href='Docs_Glucagon.html'><img src='../../Back.PNG'></a>
<p>
QHP 2008 / Glucagon.DOCS<br>
<br>
Created : 27-Mar-09<br>
Last Modified : 27-Mar-09<br>
Author : Tom Coleman<br>
Copyright : 2009<br>
<br>
&lt;structurename&gt; GlucagonPool &lt;/structurename&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; GlucagonPool.[Glucagon]&lt;/name&gt;<br>
&lt;topic&gt; Glucagon - Overview &lt;/topic&gt;<br>
&lt;topic&gt; Glucagon - Physical Units &lt;/topic&gt;<br>
&lt;topic&gt; Glucagon - Concentration Units &lt;/topic&gt;<br>
&lt;seealso&gt; GlucagonPool.Mass &lt;/seealso&gt;<br>
&lt;seealso&gt; ECFV.Vol(L) &lt;/seealso&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; GlucagonPool.Change &lt;/name&gt;<br>
&lt;topic&gt; Change - Definition1 &lt;/topic&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; GlucagonPool.Gain &lt;/name&gt;<br>
&lt;topic&gt; Gain - Definition1 &lt;/topic&gt;<br>
&lt;seealso&gt; GlucagonSecretion.Rate &lt;/seealso&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; GlucagonPool.InitialMass &lt;/name&gt;<br>
&lt;topic&gt; InitialMass - Definition1 &lt;/topic&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; GlucagonPool.Loss &lt;/name&gt;<br>
&lt;topic&gt; Loss - Definition1 &lt;/topic&gt;<br>
&lt;seealso&gt; GlucagonClearance.Rate &lt;/seealso&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; GlucagonPool.Mass &lt;/name&gt;<br>
&lt;topic&gt; Mass - Definition1 &lt;/topic&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; GlucagonPool.Target[Glucagon] &lt;/name&gt;<br>
&lt;topic&gt; Target[Glucagon] - Definition &lt;/topic&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; Glucagon - Overview &lt;/name&gt;<br>
&lt;label&gt; Overview &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
Glucagon is a single long-chain polypeptide secreted<br>
by the alpha cells of the pancreatic islets of Langerhans.<br>
It plays an important role in glucose homeostasis. <br>
It is released into the hepatic portal circulation in <br>
response to decreases in plasma glucose levels. <br>
Glucagon stimulates gluconeogenesis and glycogenolysis <br>
in the liver. Both lead to an enhanced availability of <br>
glucose. At the same time, it decreases glycogenesis<br>
and glycolysis<br>
<br>
Glucagon is the main counterregulatory hormone to insulin<br>
and the insulin to glucagon ratio determines the control <br>
of gluconeogenesis and glycogenolysis. Glucagon increases<br>
the hepatic uptake of precursors, especially amino acids,<br>
and their conversion into glucose.<br>
<br>
Kruszynska YT. Normal metabolism: the physiology of fuel<br>
homeostasis. Chapter 9, Textbook of Diabetes edited by<br>
Pickup JC & Williams G. 2003 Blackwell Science<br>
<br>
Queseda I, Tuduri E, Ripoll C, Nadal A. Physiology of<br>
the pancreatic alpha cell and glucagon secretion: role<br>
in glucose homeostasis and diabetes. <br>
J Endocrinology 199:5-19, 2008.<br>
<br>
Gromada J, Franklin I, Wollheim CB. Alpha cells of the <br>
endocrine pancreas: 35 years of research but the enigma <br>
remains. Endocrine reviews 28: 84 -116, 2007.<br>
        <br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; Glucagon - Physical Units &lt;/name&gt;<br>
&lt;label&gt; Physical Units &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
Plasma Concentration  pG/mL; pMol/L<br>
1 pG/mL = 0.282 pMol/L<br>
Mass  pG or nG<br>
Secretion nG/Min <br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; Glucagon - Concentration Units &lt;/name&gt;<br>
&lt;label&gt; Concentration Units &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
Molecular Weight (MW) of glucagon is 3550<br>
<br>
Typical plasma glucagon concentration [Glucagon] = 70 pG/mL<br>
The volume of distribution is the ECFV.<br>
<br>
Glucagon Mass = ECFV * [Glucagon]<br>
             = 15000 * 70 = 1,050,000 pG or 1,050 nG<br>
<br>
Typical glucagon concentrations under a variety of<br>
physiological situations<br>
<br>
<br>
Starve      300pG/mL    <br>
Fast        100pG/mL    <br>
Drip         70pG/mL       <br>
Meal         50pG/mL   <br>
Load         40pG/mL  <br>
<br>
Unger RH, Aguilar-Parada E, Muller WA, Eisentrant AM.<br>
Studies of pancreatic alpha cell function in normal<br>
and diabetic patients. J. Clin Invest. 49: 837-848, 1970 <br>
<br>
Felig P, Wahren J, Sherwin R, Hendler R. Insulin, glucagon,<br>
and somatostatin in normal physiology and diabetes mellitus   <br>
Diabetes 25: 1091 - 1099, 1976<br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; Gain - Definition1 &lt;/name&gt;<br>
&lt;label&gt; Definition &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
Gain is defined as positive changes in mass of glucagon<br>
and is a function of pancreatic secretion rate of glucagon.<br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; Change - Definition1 &lt;/name&gt;<br>
&lt;label&gt; Definition &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
The rate of change of glucagon mass is the gain of glucagon<br>
minus the loss of glucagon. The rate is integrated over time<br>
and divided by the ECFV to calculate plasma concentration<br>
at any given time.<br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; InitialMass - Definition1 &lt;/name&gt;<br>
&lt;label&gt; Definition &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
The initial mass is the starting amount of glucagon.<br>
It is the initial ECFV * Target[Glucagon]. The initial<br>
ECFV is affected by body traits (size, adiposity and <br>
muscularity). Target[Glucagon] is the starting plasma<br>
glucagon concentration. <br>
  <br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; Loss - Definition1 &lt;/name&gt;<br>
&lt;label&gt; Definition &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
Loss is defined as negative changes in mass of glucagon.<br>
It is a function of glucagon clearance.<br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
   <br>
&lt;topicdoc&gt;<br>
&lt;name&gt; Mass - Definition1 &lt;/name&gt;<br>
&lt;label&gt; Definition &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
Mass is the amount of glucagon at any given time.  <br>
It is a function of both gains and losses in <br>
glucagon over time. Gain is a function of pancreatic <br>
secretion rate and loss is a function of glucagon <br>
clearance rate.<br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt; <br>
&lt;topicdoc&gt;<br>
&lt;name&gt; Target[Glucagon] - Definition &lt;/name&gt;<br>
&lt;label&gt; Definition &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
Target[Glucagon] is the starting or initial plasma<br>
glucagon concentration.<br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;  <br>
<br>
End

<p><img src='../../Footer.PNG'>

</body>
</html>
